Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth.
What's in the News
- SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025. The Board will also consider approval for establishing a new facility to produce a range of Specialty Fluoropolymers (Key Developments).
- The Chemours Company has signed strategic agreements with SRF Limited to strengthen Chemours' global supply chain, enhance operational flexibility, and provide additional capacity for fluoropolymers and fluoroelastomers, which are essential materials for multiple industries (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has risen slightly from ₹3,137.83 to ₹3,138.07.
- Discount Rate changed minimally, decreasing from 13.68% to 13.68%.
- Revenue Growth projection has increased modestly from 15.23% to 15.32%.
- Net Profit Margin estimate has risen from 13.69% to 14.96%.
- Future P/E ratio is projected to fall from 43.29x to 38.83x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.